Article
Cancer stem cell hypothesis 2.0 in glioblastoma: Where are we now and where are we going?
23 Feb 2024
Abstract excerpt
Over the past 2 decades, the cancer stem cell (CSC) hypothesis has provided insight into many malignant tumors, including glioblastoma (GBM). Cancer stem cells have been identified in patient-derived tumors and in some mouse models, allowing for a deeper understanding of cellular and molecular mechanisms underlying GBM growth and therapeutic resistance. The CSC hypothesis has been the cornerstone of cellular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
